JUVENTAS THERAPEUTICS INC has a total of 13 patent applications. Its first patent ever was published in 2008. It filed its patents most often in Australia, United States and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are HASUMI KENICHIRO, TILLOTTS PHARMA AG and HANMI PHARM CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | United States | 2 | |
#3 | Canada | 1 | |
#4 | China | 1 | |
#5 | EAPO (Eurasian Patent Organization) | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Mexico | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Syringes | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Penn Marc S | 13 |
#2 | Pastore Joseph | 13 |
#3 | Aras Rahul | 13 |
#4 | Kiedrowski Matthew | 11 |
#5 | Miller Timothy J | 2 |
#6 | Fisher Scott J | 1 |
Publication | Filing date | Title |
---|---|---|
KR20160005333A | The use of sdf-1 to mitigate scar formation | |
AU2010286511A1 | SDF-1 delivery for treating ischemic tissue |